CCR9 and inflammatory bowel disease: It may be important to know whether CCR9 inhibition or intestinal resection would result in the hepatic accumulation of pDCs in humans, especially for patients with primary sclerosing cholangitis, 70% of whom have complications of inflammatory bowel disease.